187 related articles for article (PubMed ID: 15212593)
1. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
Frueh FW; Gurwitz D
Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: the promise of personalized medicine.
Hood E
Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
[No Abstract] [Full Text] [Related]
4. Personalized medicine prompts push to redesign clinical trials.
Singer E
Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
[No Abstract] [Full Text] [Related]
5. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
6. Assessment of healthcare professionals'Â knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
[No Abstract] [Full Text] [Related]
7. The disruptive nature of personalized medicine technologies: implications for the health care system.
Carlson RJ
Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
[TBL] [Abstract][Full Text] [Related]
8. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. The Personalized Medicine Coalition: goals and strategies.
Abrahams E; Ginsburg GS; Silver M
Am J Pharmacogenomics; 2005; 5(6):345-55. PubMed ID: 16336000
[TBL] [Abstract][Full Text] [Related]
11. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
12. Educating for personalized medicine: a perspective from oncology.
Parkinson DR; Ziegler J
Clin Pharmacol Ther; 2009 Jul; 86(1):23-5. PubMed ID: 19536120
[TBL] [Abstract][Full Text] [Related]
13. The conundrum of personalized cancer management, drug development, and economics.
DeNardo GL
Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
[No Abstract] [Full Text] [Related]
14. Commentary: where and how could biomarkers be used in 2016?
Finley Austin MJ; Babiss L
AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
[TBL] [Abstract][Full Text] [Related]
15. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
Ciarleglio AE; Ma C
Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
[TBL] [Abstract][Full Text] [Related]
16. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
[TBL] [Abstract][Full Text] [Related]
17. Awareness survey of parties involved in pharmacogenomics in Japan.
Tamaoki M; Gushima H; Tsutani K
Pharmacogenomics; 2007 Mar; 8(3):275-86. PubMed ID: 17324116
[TBL] [Abstract][Full Text] [Related]
18. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
Musgrave E
Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
[No Abstract] [Full Text] [Related]
19. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.
Roman YM; Dixon DL; Salgado TM; Price ET; Zimmerman KM; Sargent L; Slattum PW
Pharmacogenomics; 2020 Jun; 21(9):627-635. PubMed ID: 32425117
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]